These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27522034)

  • 1. The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study.
    Farmer AJ; Oke J; Hardeman W; Tucker L; Sutton S; Kinmonth AL; Griffin S; Holman RR
    Diabetes Res Clin Pract; 2016 Oct; 120():56-64. PubMed ID: 27522034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning.
    Dakin HA; Farmer A; Gray AM; Holman RR
    Value Health; 2020 Oct; 23(10):1340-1348. PubMed ID: 33032778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.
    Holman RR; Paul S; Farmer A; Tucker L; Stratton IM; Neil HA;
    Diabetologia; 2009 Jan; 52(1):50-9. PubMed ID: 19002433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care.
    Griffin SJ; Simmons RK; Williams KM; Prevost AT; Hardeman W; Grant J; Whittle F; Boase S; Hobbis I; Brage S; Westgate K; Fanshawe T; Sutton S; Wareham NJ; Kinmonth AL;
    BMC Public Health; 2011 Apr; 11():211. PubMed ID: 21463520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence.
    Pakpour AH; Gholami M; Esmaeili R; Naghibi SA; Updegraff JA; Molloy GJ; Dombrowski SU
    Epilepsy Behav; 2015 Nov; 52(Pt A):133-42. PubMed ID: 26414343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication.
    Farmer AJ; Prevost AT; Hardeman W; Craven A; Sutton S; Griffin SJ; Kinmonth AL;
    BMC Fam Pract; 2008 Apr; 9():20. PubMed ID: 18405345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
    Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
    Trials; 2015 Dec; 16():547. PubMed ID: 26631181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
    Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
    Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a nurse-led behaviour change intervention to support medication taking in type 2 diabetes: beyond hypothesised active ingredients (SAMS Consultation Study).
    Hardeman W; Lamming L; Kellar I; De Simoni A; Graffy J; Boase S; Sutton S; Farmer A; Kinmonth AL
    Implement Sci; 2014 Jun; 9():70. PubMed ID: 24902481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes.
    Farmer A; Hardeman W; Hughes D; Prevost AT; Kim Y; Craven A; Oke J; Boase S; Selwood M; Kellar I; Graffy J; Griffin S; Sutton S; Kinmonth AL
    BMC Fam Pract; 2012 Apr; 13():30. PubMed ID: 22480341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.
    Neil HA; Ceglarek U; Thiery J; Paul S; Farmer A; Holman RR
    Atherosclerosis; 2010 Dec; 213(2):512-7. PubMed ID: 21036355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial.
    Buhse S; Kuniss N; Liethmann K; Müller UA; Lehmann T; Mühlhauser I
    BMJ Open; 2018 Dec; 8(12):e024004. PubMed ID: 30552272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes.
    Reese PP; Kessler JB; Doshi JA; Friedman J; Mussell AS; Carney C; Zhu J; Wang W; Troxel A; Young P; Lawnicki V; Rajpathak S; Volpp K
    J Gen Intern Med; 2016 Apr; 31(4):402-10. PubMed ID: 26585957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication.
    Rash JA; Lavoie KL; Sigal RJ; Campbell DJ; Manns BJ; Tonelli M; Campbell TS
    Contemp Clin Trials; 2016 Jul; 49():47-56. PubMed ID: 27282119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial on the effect of behavioral strategies for adherence to oral antidiabetic drugs: study protocol.
    Trevisan DD; São-João TM; Cornélio ME; Jannuzzi FF; Rodrigues RCM; Lima MHM
    Contemp Nurse; 2017 Dec; 53(6):658-668. PubMed ID: 29281941
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.